Nanhua Bio-Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
October 29, 2019 at 05:21 pm IST
Share
NanHua Bio-medicine Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 90.235 million compared to CNY 55.784 million a year ago. Operating loss was CNY 19.274 million compared to CNY 22.613 million a year ago. Net loss was CNY 20.088 million compared to CNY 23.010 million a year ago. Basic loss per share from continuing operations was CNY 0.0645 compared to CNY 0.0739 a year ago.
Landfar Bio medicine Co Ltd is a China-based company mainly engaged in the biomedical and energy conservation & environmental protection business. The Companyâs biomedical business includes stem cell storage and technical services, stem cell treatment research, medical instrument purchasing & sales. The Companyâs energy conservation & environmental protection business includes energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The Company is involved in other businesses related to aid and build project. The Company mainly conducts businesses within the domestic market.